Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Treatment for Syndromes of Dementia and Movement Disorders Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Movement Disorders
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
          4.2.3 Parkinson’s Disease
          4.2.4 Progressive Supranuclear Palsy
          4.2.4 Multiple System Atrophy
          4.2.6 Hallervorden-Spatz Disease
          4.2.7 Others
    4.3 Progressive Dementia
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
          4.3.3 Alzheimer’s Disease
          4.3.4 Lewy Body Dementia
          4.3.5 Frontotemporal Dementia/Pick
          4.3.6 Others
    4.4 Progressive Dementia with Neurological Abnormality
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
          4.4.3 Huntington’s Disease
          4.4.4 Corticobasal Ganglionic Degeneration
          4.4.5 Amyotrophic Lateral Sclerosis(ALS)
Chapter 5 Treatment for Syndromes of Dementia and Movement Disorders Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 US
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 UK
                   5.3.3.1 Market Size and Forecast
          5.3.4 Germany
                   5.3.4.1 Market Size and Forecast
          5.3.5 France
                   5.3.5.1 Market Size and Forecast
          5.3.6 Italy
                   5.3.6.1 Market Size and Forecast
          5.3.7 Spain
                   5.3.7.1 Market Size and Forecast
          5.3.8 Others
                   5.3.8.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 Japan
                   5.4.3.1 Market Size and Forecast
          5.4.4 China
                   5.4.4.1 Market Size and Forecast
          5.4.5 India
                   5.4.5.1 Market Size and Forecast
          5.4.6 Others
                   5.4.6.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 Valeant Pharmaceutical International
    6.2 AstraZeneca GmbH
    6.3 F. Hoffmann-La Roche, AG
    6.4 Abbott Laboratories, Inc.
    6.5 Merck & Co., Inc.
    6.6 Sanofi S.A.
    6.7 Novartis AG
    6.8 Bristol-Myers Squibb
    6.9 Baxter International, Inc.
    6.10 Pfizer, Inc.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report